Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Quantitative carcinogenesis in relation to human exposures.

Berenblum I.

Cancer Detect Prev. 1988;11(3-6):135-7.

PMID:
3390839
2.

Challenging problems in cocarcinogenesis.

Berenblum I.

Cancer Res. 1985 May;45(5):1917-21. No abstract available.

3.

A possible in vivo skin model for tumour promoter assays.

Armuth V, Berenblum I.

Cancer Lett. 1982 Mar-Apr;15(3):343-6. No abstract available.

PMID:
7116336
4.

Further exploration of stages in carcinogenesis.

Armuth V, Berenblum I.

Carcinog Compr Surv. 1982;7:41-2. No abstract available.

PMID:
7066925
5.

Two independent aspects of tumor promotion.

Berenblum I, Armuth V.

Biochim Biophys Acta. 1981 Aug 31;651(1):51-63. Review. No abstract available.

PMID:
7025906
6.

Cancer prevention as a realizable goal.

Berenblum I.

Cancer. 1981 May 15;47(10):2346-8. No abstract available.

PMID:
7272890
7.
8.

Some basic problems in assessing carcinogenic risks.

Berenblum I.

Br J Cancer. 1980 Mar;41(3):490-3. No abstract available.

10.
11.

Systemic promoting action and leukemogenesis in SWR mice by phorbol and structurally related polyfunctional diterpenes.

Armuth V, Berenblum I, Adolf W, Opferkuch HJ, Schmidt R, Sorg B, Hecker E.

J Cancer Res Clin Oncol. 1979 Sep;95(1):19-28.

PMID:
500766
12.
13.

Established principles and unresolved problems in carcinogenesis.

Berenblum I.

J Natl Cancer Inst. 1978 Apr;60(4):723-6. Review. No abstract available.

PMID:
344897
14.

Possible two-stage transplacental liver carcinogenesis in C57BL/6 mice.

Armuth V, Berenblum I.

Int J Cancer. 1977 Aug 15;20(2):292-5.

PMID:
197029
15.
16.

Cancer research in historical perspective: an autobiographical essay.

Berenblum I.

Cancer Res. 1977 Jan;37(1):1-7. No abstract available.

17.

Phorbol as a possible systemic promoting agent for skin carcinogenesis.

Armuth V, Berenblum I.

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Jan 2;85(1):79-82.

PMID:
129971
18.

Inhibition of radiation-induced lymphatic leukemia in C57BL mice by 19S alpha-2-globulin (alpha 2-MG) from human blood serum.

Berenblum I, Burger M, Knyszynski A.

Radiat Res. 1974 Dec;60(3):501-5. No abstract available.

PMID:
10881727
19.

Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats.

Armuth V, Berenblum I.

Cancer Res. 1974 Oct;34(10):2704-7. No abstract available.

20.

Systemic promoting action of phorbol in liver and lung carcinogenesis in AKR mice.

Armuth V, Berenblum I.

Cancer Res. 1972 Oct;32(10):2259-62. No abstract available.

21.

A cytological study of bone marrow and peripheral blood of irradiated and nonirradiated mice treated with 19S alpha-2 globulin (alpha-2-MG).

Sontag JM, Berenblum I, Trainin N.

Radiat Res. 1971 Mar;45(3):511-21. No abstract available.

PMID:
4102389
22.

A quantitative analysis of bone marrow cell populations in irradiated and nonirradiated mice treated with 19S alpha-2 globulin (alpha-2-MG).

Sontag JM, Trainin N, Berenblum I.

Radiat Res. 1971 Mar;45(3):499-510. No abstract available.

PMID:
4102388
23.

The leukemogenic action of phorbol.

Berenblum I, Lonai V.

Cancer Res. 1970 Nov;30(11):2744-8. No abstract available.

24.

Stimulation of thymic and bone marrow regeneration in irradiated mice by protein fractions of human serum and sheep spleen.

Burger M, Knyszynski A, Berenblum I.

Radiat Res. 1969 Oct;40(1):193-202. No abstract available.

PMID:
4186071
25.

Comparative study of lung carcinogenesis, promoting action in leukaemogenesis and initiating action in skin tumorigenesis by urethane, hydrazine and related compounds.

Mirvish SS, Chen L, Haran-Ghera N, Berenblum I.

Int J Cancer. 1969 May 15;4(3):318-26. No abstract available.

PMID:
5801419
26.

A re-evaluation of the concept of cocarciongenesis.

Berenblum I.

Prog Exp Tumor Res. 1969;11:21-30. Review. No abstract available.

PMID:
4891849
27.

A quantitative study of the leukemogenic action of whole-body x-irradiation and urethane. II. In newborn C57BL mice.

Chen L, Berenblum I.

Isr J Med Sci. 1968 Nov-Dec;4(6):1164-8. No abstract available.

PMID:
5756643
28.

A quantitative study of the leukemogenic action of whole-body x-irradiation and urethane. I. In adult C57BL mice.

Berenblum I, Chen L, Trainin N.

Isr J Med Sci. 1968 Nov-Dec;4(6):1159-63. No abstract available.

PMID:
5756642
29.

Failure of syngeneic bone marrow cells to protect against MC-induced lymphoma in dba-2 mice.

Chen L, Berenblum I.

Br J Cancer. 1968 Sep;22(3):582-7. No abstract available.

30.

Regeneration of bone marrow cells and thymus induced by 19S alpha-2 globulin in irradiated mice.

Berenblum I, Burger M, Knyszynski A.

Nature. 1968 Mar 2;217(5131):857-8. No abstract available.

PMID:
5641150
31.

Conditions affecting the inhibitory action of RLP on radiation leukaemogenesis in mice.

Berenblum I, Trainin N, Cividalli G, Boiato-Chen L, Knyszynski A.

Tumori. 1967 Jan-Feb;53(1):5-17. No abstract available.

PMID:
6059117
32.

Precision in cancer terminology.

Berenblum I.

Indian J Cancer. 1966 Sep;3(3):154-6. No abstract available.

PMID:
5917022
33.

Influence of thymectomy and subsequent thymus implantation on leukemia induction in adult C57BL mice by radiation and urethan.

Berenblum I, Boiato-Chen L, Trainin N.

Cancer Res. 1966 Jul;26(7):1383-5. No abstract available.

34.

The carcinogenic action and metabolism of N-hydroxyurethane in newborn mice.

Boiato L, Mirvish SS, Berenblum I.

Int J Cancer. 1966 May 15;1(3):265-9. No abstract available.

PMID:
5952686
35.
36.
37.

SOME PROPERTIES OF "RLP"--A FACTOR FROM SHEEP SPLEEN CAPABLE OF INHIBITING RADIATION LEUKEMOGENESIS IN MICE.

BERENBLUM I, CIVIDALLI G, TRAININ N, HODES ME.

Blood. 1965 Jul;26:8-19. No abstract available.

PMID:
14314404
38.

The catabolism of urethan in young mice of varying age and strain, and in x-irradiated mice, in relation to urethan carcinogenesis.

Cividalli G, Mirvish SS, Berenblum I.

Cancer Res. 1965 Jul;25(6):855-8. No abstract available.

39.

A FACTOR ('RLP') FROM SHEEP SPLEEN WHICH INHIBITS RADIATION LEUKAEMOGENESIS IN MICE.

BERENBLUM I, CIVIDALLI G, HODES ME, TRAININ N.

Nature. 1964 Jun 6;202:973-4. No abstract available.

PMID:
14197329
40.

SLOW ELIMINATION OF URETHAN IN RELATION TO ITS HIGH CARCINOGENICITY IN NEWBORN MICE.

MIRVISH S, CIVIDALLI G, BERENBLUM I.

Proc Soc Exp Biol Med. 1964 Jun;116:265-8. No abstract available.

PMID:
14189113
41.

ACTION OF ISOLOGOUS BONE MARROW FROM URETHAN-TREATED C57BL-6 MICE ON RADIATION LEUKEMOGENESIS.

BERENBLUM I, BOIATO L, FIOREDONATI L, TRAININ N.

J Natl Cancer Inst. 1964 Mar;32:723-9. No abstract available.

PMID:
14133647
42.

INFLUENCE OF MUTAGENS ON THE INITIATION OF SKIN CARCINOGENESIS.

TRAININ N, KAYE AM, BERENBLUM I.

Biochem Pharmacol. 1964 Feb;13:263-7. No abstract available.

PMID:
14129406
43.

RADIATION, URETHANE, AND A "TRANSMISSIBLE FACTOR" IN EXPERIMENTAL LEUKAEMOGENESIS.

BERENBLUM I.

Acta Unio Int Contra Cancrum. 1964;20:893-8. No abstract available.

PMID:
14274748
44.
45.

A possible two-stage mechanism in rhabdomyosarcoma induction in rats.

HARAN-GHERA N, TRAININ N, FIORE-DONATI L, BERENBLUM I.

Br J Cancer. 1962 Dec;16:653-64. No abstract available.

46.

Leukemogenesis by urethan in C57B1 mice bearing isologous tissues from x-irradiated mice.

BERENBLUM I, TRAININ N.

Science. 1961 Dec 22;134(3495):2045-7.

PMID:
13867499
47.

Failure of bone marrow to interfere with the augmentation of x-ray leukemogenesis by urethan.

BERENBLUM I, REWALD FE, TRAININ N.

J Natl Cancer Inst. 1961 Dec;27:1361-7. No abstract available.

PMID:
13867498
48.

Possible two-stage mechanism in experimental leukemogenesis.

BERENBLUM I, TRAININ N.

Science. 1960 Jul 1;132(3418):40-1.

PMID:
13799157
49.

In vivo tests for a carcinogenic metabolite in plasma of animals given injections of ethyl carbamate (urethan).

BERENBLUM I, KAYE AM, TRAININ N.

Cancer Res. 1960 Jan;20:38-43. No abstract available.

50.

Supplemental Content

Loading ...
Support Center